1. Home
  2. PBYI vs QIPT Comparison

PBYI vs QIPT Comparison

Compare PBYI & QIPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
    SELLHOLDBUYas of 4 hours ago
  • QIPT
    SELLHOLDBUYas of 4 hours ago
  • Stock Information
  • Founded
  • PBYI 2010
  • QIPT 1993
  • Country
  • PBYI United States
  • QIPT United States
  • Employees
  • PBYI N/A
  • QIPT N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • QIPT
  • Sector
  • PBYI Health Care
  • QIPT
  • Exchange
  • PBYI Nasdaq
  • QIPT Nasdaq
  • Market Cap
  • PBYI 153.2M
  • QIPT 129.3M
  • IPO Year
  • PBYI N/A
  • QIPT N/A
  • Fundamental
  • Price
  • PBYI $3.02
  • QIPT $3.05
  • Analyst Decision
  • PBYI Strong Buy
  • QIPT Strong Buy
  • Analyst Count
  • PBYI 1
  • QIPT 3
  • Target Price
  • PBYI $7.00
  • QIPT $7.67
  • AVG Volume (30 Days)
  • PBYI 821.4K
  • QIPT 298.2K
  • Earning Date
  • PBYI 02-27-2025
  • QIPT 02-12-2025
  • Dividend Yield
  • PBYI N/A
  • QIPT N/A
  • EPS Growth
  • PBYI 492.79
  • QIPT N/A
  • EPS
  • PBYI 0.47
  • QIPT N/A
  • Revenue
  • PBYI $243,569,000.00
  • QIPT $245,915,000.00
  • Revenue This Year
  • PBYI N/A
  • QIPT $7.34
  • Revenue Next Year
  • PBYI N/A
  • QIPT $6.20
  • P/E Ratio
  • PBYI $6.38
  • QIPT N/A
  • Revenue Growth
  • PBYI 6.30
  • QIPT 16.17
  • 52 Week Low
  • PBYI $2.23
  • QIPT $2.30
  • 52 Week High
  • PBYI $7.73
  • QIPT $4.99
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 46.61
  • QIPT 56.11
  • Support Level
  • PBYI $2.94
  • QIPT $2.80
  • Resistance Level
  • PBYI $4.06
  • QIPT $3.03
  • Average True Range (ATR)
  • PBYI 0.25
  • QIPT 0.18
  • MACD
  • PBYI -0.04
  • QIPT 0.01
  • Stochastic Oscillator
  • PBYI 6.14
  • QIPT 71.07

Stock Price Comparison Chart: PBYI vs QIPT

PBYI
QIPT
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober202501234567891011121314PBYI VS QIPT

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About QIPT Quipt Home Medical Corp.

Quipt Home Medical Corp provides in-home monitoring equipment, supplies, and services to patients. The Company operates in one business segment, which is the sale and rental of medical equipment and related devices. The company's services consist of Daily and Ambulatory Aides, Power Mobility, INR Self-Testing, Respiratory Equipment Rental, Home ventilation, Oxygen Therapy, and Sleep Apnea and PAP Treatment.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use